We have recently demonstrated a strong synergy between muscarinic and 28 adrenergic excitatory pathways in the trigone which, as part of the bladder base, 29 plays a key role in outflow control. This study aimed to characterise the role of 30 
Abstract 26 27
We have recently demonstrated a strong synergy between muscarinic and 28 adrenergic excitatory pathways in the trigone which, as part of the bladder base, 29 plays a key role in outflow control. This study aimed to characterise the role of 30 intracellular Ca 2+ , [Ca 2+ ] i , in this synergistic effect. Muscle strips from the superficial 31 trigone of male guinea-pigs were used for tension experiments. In isolated muscle 32 cells, [Ca 2+ ] i was measured by epifluorescence microscopy using the fluorescent 33 contractile proteins is likely to play a key role in this synergism, particularly for 44 adrenergic activation. 45
Introduction 50 51
We recently described a strong mutual interaction between adrenergic and 52 muscarinic contractile activation in the bladder trigone [1] . In this study, 10 µM of the 53 alpha-1-agonist phenylephrine (PE) was effective in enhancing contractions elicited 54 by electrical-field stimulation, as well as by exposure to other agonists. The 55 superficial trigone develops, with the ureter, from an outgrowth of the mesonephric 56 duct and provides, as a transverse-orientated interureteric muscle, competent vesico-57 ureteric anchoring. Situated between the ureteric orifices and bladder outlet, it is 58 considered to play a crucial role in uretero-vesical function, continence and 59 ] i was measured by epifluorescence microscopy using the fluorescent Ca To evaluate the potentiating effect of α-adrenoreceptor (α-AR) stimulation on 178 responses to the muscarinic agonist carbachol, intact trigonal preparations were first 179 challenged with 1 µM carbachol for 1 min as a control response, then superfused by 180 10 µM PE for 4 min., immediately followed by a combined intervention of 10 µM PE 181 and 1 µM carbachol for 1 min (Fig. 2 A) ] i (Fig. 2, B (Fig. 2 C and D) . ] i levels in the 228 trigone when evoked by PE (Fig. 4 A, B) . Pre-incubation with GF 109203X (30 min) 229 caused a reduction of the PE contracture to 37.3 ± 9.4 % of control (n = 14). 
The effect of PKC and ROK inhibition on the potentiated muscarinic component 237 238
To explore further the hypothesis that the synergy described above between 239 adrenergic and muscarinic activation is due to kinase activity, we incubated muscle 240 strips with the PKC or ROK inhibitor for 30 min. The preparation was then superfused 241 with 10 M PE alone, followed by the combined intervention (10 M PE + 1 M 242 carbachol), and the enhanced muscarinic component compared to that from 1 M 243 carbachol alone (Fig. 4 C) . Similar results were obtained when the sequence of the 244 interventions was changed. There was still a significant, but greatly reduced increase 245 of force (145.7 ± 14.5 %, n = 5, vs. 404.8 ± 84.6 % of control) after PKC inhibition. 246
Incubation with the ROK inhibitor, in turn, reduced the potentiating effect by a 247 smaller, but still significantly different, degree (295.8 ± 34.24 %, n = 4, of control). 
Cellular synergism is mediated through calcium sensitisation 251 252
In contrast to previously reported facilitation of acetylcholine release by prejunctional 253 -ARs in the detrusor [16] , the force-potentiating interaction between adrenergic and 254 muscarinic neurotransmission in the trigone is a true synergistic effect on the muscle 255 cells themselves. In this study, we measured changes to [Ca 2+ ] i in parallel 256 experiments to tension recording. It is important to note that the same cell responded 257 to both muscarinic and adrenergic stimulation, discounting the possibility that the 258 dual innervation of the trigone might be a mere result of two distinct cell populations. 259
The strong synergistic effect seen when recording tension with intact muscle 260 
Conclusion 336
This study demonstrates that the adrenergic pathway in the bladder trigone mainly 337 operates through Ca 2+ -sensitisation and is thereby capable of a more than 4-fold 338 potentiation of muscarinic force activation. It supports recent reports about the high 339 effectiveness of a combined anti-muscarinic and anti-adrenergic therapy in patients 340 with both OAB and outflow obstruction. 341 342 343
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